Skip to main content
Fig. 5 | Cell Communication and Signaling

Fig. 5

From: LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition

Fig. 5

JNK/p38 MAPK inactivation is required for LASP2-medatied cell behaviors in CRC cells. a Western blot analysis of marks of MAPK pathway and EMT after treatment with JNK inhibitor JNK inhibitor II and p38 inhibitor SB203580 in LASP2 down-regulated CRC cell line SW620. Immunosignals of protein expression level were quantified by greyscale scanning software and relative protein abundance was normalized by β-tubulin. b Representative figures of transwell assay after treatment of JNK inhibitor JNK inhibitor II and p38 inhibitor SB203580. Error bars represent mean SD averaged from 3 independent experiments. (#) indicates not statistic significant while (*) indicate P < 0.05 and (**) P < 0.01

Back to article page